Previous 10 | Next 10 |
NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Cla...
San Francisco, California--(Newsfile Corp. - June 16, 2022) - Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now . The firm is investigating possible securities law violations. Visit: www.hbsslaw.com/investor...
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), Novartis AG (NYSE: NVS), and Corcept Therapeutics,...
San Francisco, California--(Newsfile Corp. - June 6, 2022) - Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now . The firm is investigating possible securities law violations. Visit: www.hbsslaw.com/investor-fr...
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc. (NASDAQ: ENOB), Novartis AG (NYSE: NVS), Teladoc Health, Inc. (NYSE: TDOC), and Tupperware B...
NEW YORK, NY / ACCESSWIRE / June 1, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Enochian Biosciences, Inc. ("Enochian" or the "Company") (NASDAQ:ENOB). If you suffered losses exceeding $50,000 investing in Enochian stoc...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: motorolka / Shutterstock.com ENOB stock is plummeting more than 30% today after Hindenburg Research released a short report on the company. Enochian Biosciences’ co-founder and largest shareholder, Serh...
Gainers: Tonix Pharmaceuticals Holding (TNXP) +60%. Helius Medical Technologies (HSDT) +40%. View (VIEW) +42%. Spark Networks (LOV) +32%. Regencell Bioscience Holdings (RGC) +21%. 180 Life Sciences (ATNF) +20%. Evelo Biosciences (EVLO) +17%. NeuroOne Medical Technologies Corporation (NMTC) +1...
Gainers: Helius Medical Technologies (HSDT) +57%. Tonix Pharmaceuticals TNXP +49%. NeuroOne Medical Technologies (NMTC) +16%. Oncternal Therapeutics (ONCT) +16%. Butterfly Network (BFLY) +15%. Losers: Enochian Biosciences ENOB -37%. Icosavax ...
Enochian Biosciences (NASDAQ:ENOB) plummeted 25% after Hindenburg Research released a full short report on the company after it teased one last week after the company's co-founder was arrested in an alleged murder-for-hire plot. Enochian Biosciences’ co-founder and largest shareho...
News, Short Squeeze, Breakout and More Instantly...
Enochian Biosciences Inc. Company Name:
ENOB Stock Symbol:
NASDAQ Market:
LOS ANGELES, June 23, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc., a company developing gene-modified cell immunotherapies for cancer and infectious diseases, wishes to advise that its 2023 Annual Stockholder Meeting (the “Annual Meeting”), which was sched...